{
  "age": 55,
  "gender": {
    "category": "Male",
    "intersex_condition": null
  },
  "weight": {
    "weight_kg": 85,
    "height_cm": 175,
    "bmi_category": "Obese"
  },
  "ethnicity": "Middle Eastern",
  "disease": {
    "name": "Hyperthyroidism",
    "diagnosed_years_ago": 7,
    "prognosis": "Terminal"
  },
  "comorbidities": [
    {
      "name": "Congestive Heart Failure",
      "diagnosed_years_ago": 2,
      "prognosis": "Worsening"
    }
  ],
  "treatments": [
    {
      "treatment_name": "Propylthiouracil",
      "dosage_mg_per_day": 100,
      "percent_week_administered": 800,
      "indication": "Primary"
    },
    {
      "treatment_name": "Furosemide",
      "dosage_mg_per_day": 40,
      "percent_week_administered": 100,
      "indication": "Secondary"
    },
    {
      "treatment_name": "Spironolactone",
      "dosage_mg_per_day": 25,
      "percent_week_administered": 100,
      "indication": "Secondary"
    }
  ],
  "genetic_variants": [
    {
      "gene": "CYP2D6",
      "variant": "*4/*5",
      "effect": "Poor metabolizer; may impact beta-blockers or other adjunct therapies"
    },
    {
      "gene": "TSHR",
      "variant": "rs2268458",
      "effect": "Associated with increased hyperthyroidism risk"
    }
  ]
}









